Evidence map›Paper›PMID 31809227›Full record

ArticleCell cycle (Georgetown, Tex.)2020

MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.

Ruo-Huang Lu, Zhi-Qiang Xiao, Jian-Da Zhou, Chao-Qi Yin, Zi-Zi Chen, Feng-Jie Tang, Shao-Hua Wang

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2021
    Review
  13. Noncoding RNAs: emerging players in skin cancers pathogenesis.American journal of cancer research · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ruo-Huang LuDepartment of Stomatology, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.
Zhi-Qiang XiaoThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital, Central South University, Changsha 410008, P.R. China.
Jian-Da ZhouDepartment of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.
Chao-Qi YinDepartment of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.
Zi-Zi ChenDepartment of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.
Feng-Jie TangDepartment of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.
Shao-Hua WangDepartment of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, P.R. China.ORCID 0000-0001-9267-1378
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumorigenic cancer stem cells (CSCs) exist in various tumors including the cutaneous squamous cell carcinoma (cSCC) as a minor subpopulation and are tightly associated with metastasis and therapeutic resistance. Better understanding of CSCs properties is essential for the novel therapeutic strategy targeted toward these cancers. The cSCC stem cells (cSCCSCs) were enriched from a cSCC cell line A431 by repeated sphere culture, and identified via the expression analysis of stemness marker genes and CD44 proteolysis. MiR-199a-5p was previously reported to be related with the proteolysis modulation of CD44, so the specific regulation mechanisms were verified by overexpression

Indexed as

Signal TransductionAnimalsBase SequenceCarcinoma, Squamous CellCell Line, TumorCell NucleusGene Expression Regulation, NeoplasticGene SilencingHumansHyaluronan ReceptorsMice, Inbred BALB CMice, NudeMicroRNAsNeoplasm MetastasisNeoplastic Stem CellsProtein DomainsCD44 protein, humanHyaluronan ReceptorsMicroRNAsmirn199 microRNA, humanSirtuin 1Cancer stem cellsCD44Cutaneous squamous cell carcinoma

Identifiers

PMID31809227
PMCPMC6927716
OpenAlexW2993259978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.